Table 5

Primary and Secondary Endpoints at 9 Months Stratified by Side Branch Size

Tryton StentProvisionalp Value
Side branches <2.25 mmN = 208N = 205
 TVF44/203 (21.7)20/195 (10.3)0.002
 Cardiac death0/201 (0.0)0/194 (0.0)
 Target vessel MI39/203 (19.2)18/195 (9.2)0.006
 Clinically driven TVR11/201 (5.5)6/195 (3.1)0.32
 In-segment SB % diameter stenosis32.35 ± 23.2636.79 ± 14.990.13
Side branches ≥2.25 mmN = 146N = 143
 TVF16/141 (11.3)22/141 (15.6)0.38
 Cardiac death0/141 (0.0)0/139 (0.0)
 Target vessel MI13/141 (9.2)17/141 (12.1)0.56
 Clinically driven TVR5/141 (3.5)6/139 (4.3)0.77
 In-segment SB % diameter stenosis30.43 ± 22.5340.61 ± 17.200.004

Values are n/N (%) or mean ± SD. Nonhierarchical intention-to-treat population.

Abbreviations as in Tables 1 and 3.

  • TVF is defined as cardiac death, target vessel MI, or clinically driven TVR.

  • From the angiographic cohort: n = 94 for Tryton group and n = 87 for provisional group.

  • From the angiographic cohort: n = 64 for Tryton group and n = 81 for provisional group.